Cryo-Cell International's total inventories for the quarter that ended in Feb. 2024 was $0.76 Mil. Cryo-Cell International's average total inventories from the quarter that ended in Nov. 2023 to the quarter that ended in Feb. 2024 was $0.76 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Cryo-Cell International's Net-Net Working Capital per share for the quarter that ended in Feb. 2024 was $-7.95.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cryo-Cell International's Days Inventory for the
three
months ended in Feb. 2024 was 32.19.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cryo-Cell International's Inventory Turnover for the quarter that ended in Feb. 2024 was 2.83.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cryo-Cell International's Inventory-to-Revenue for the quarter that ended in Feb. 2024 was 0.10.
Cryo-Cell International Total Inventories Historical Data
The historical data trend for Cryo-Cell International's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Cryo-Cell International Annual Data
Trend
Nov14
Nov15
Nov16
Nov17
Nov18
Nov19
Nov20
Nov21
Nov22
Nov23
Total Inventories
1.09
0.93
0.92
0.85
0.77
Cryo-Cell International Quarterly Data
May19
Aug19
Nov19
Feb20
May20
Aug20
Nov20
Feb21
May21
Aug21
Nov21
Feb22
May22
Aug22
Nov22
Feb23
May23
Aug23
Nov23
Feb24
Total Inventories
0.90
0.88
1.06
0.77
0.76
Cryo-Cell International Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Cryo-Cell International (AMEX:CCEL) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Cryo-Cell International's Net-Net Working Capital Per Share for the quarter that ended in Feb. 2024 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cryo-Cell International's Inventory to Revenue for the quarter that ended in Feb. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Cryo-Cell International Total Inventories Related Terms
Thank you for viewing the detailed overview of Cryo-Cell International's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
Cryo-Cell International (Cryo-Cell International) Business Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCEL has been successfully added to your 